Lorbrena 00069-0227
Generic: Lorlatinib
Product NDC
00069-0227- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- November 19, 2018
- Listing Expires
- December 31, 2027
- Application
- NDA210868
Need to source Lorbrena? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lorlatinib | 25 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Breast Cancer Resistance Protein Inhibitors [MoA]Cytochrome P450 2B6 Inducers [MoA]
Packaging Options(2)
30 TABLET, FILM COATED in 1 BOTTLE (0069-0227-01)
120 TABLET, FILM COATED in 1 BOTTLE (0069-0227-03)